Some risk factors for epithelial ovarian cancer are modifiable, according to a study published online Jan. 6 in the I ...

If approved, the combination regimen would be the first FDA-approved treatment for adults with recurrent KRAS mutant low-grade serous ovarian cancer (LGSOC).

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

Background: Pathological response to neoadjuvant treatment for patients with high-grade serous ovarian carcinoma (HGSOC) is assessed using the chemotherapy response score (CRS) for omental tumor ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.

A Pap smear or Pap test is a screening test for cervical cancer. There’s currently no easy and reliable early screening test for ovarian cancer. A Pap smear or Pap test doesn’t help doctors ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share estimates for Zentalis Pharmaceuticals in a research note issued on Wednesday, February 5th. Leerink Partnrs ...

Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced the publication of "Characterization of plasma cell-free DNA variants as of ...